In focus · trending topic

neurostimulation

8 stories · following the connections

Helius Medical Technologies Announces Positive Results from its Registrational Clinical Trial for Traumatic Brain Injury (TBI)

By Nasdaq OMXNov 9, 2017, 11:01 AM UTC

SPR Therapeutics® Secures $25 Million in Series C Financing

By Nasdaq OMXSep 12, 2017, 12:03 PM UTC

SPR Therapeutics Promotes Dr. Joseph Boggs to SVP of Research and Development

By Nasdaq OMXSep 7, 2017, 1:13 PM UTC

Opioid Concerns and Work Interference Cited as Top Reasons to Delay Knee Replacement Surgery

By Nasdaq OMXAug 3, 2017, 3:03 PM UTC

SPR Therapeutics Awarded $6M Contract From the United States Department of Defense to Advance Non-Opioid Pain Relief Therapy

By Nasdaq OMXMay 15, 2017, 1:04 PM UTC

SPR Therapeutics Appoints Michael P. Chuisano to Board of Directors

By Nasdaq OMXMar 21, 2017, 1:33 PM UTC

Les C. Vinney Named 2016 NACD Top 100 Directors

By Nasdaq OMXJan 19, 2017, 2:30 PM UTC

SPR Therapeutics Names Dave Youngberg Vice President of Sales

By Nasdaq OMXJan 17, 2017, 2:30 PM UTC